Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Conclusions and clinical perspectives

Date

08 Oct 2016

Session

Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancer

Presenters

Solange Peters

Authors

S. Peters

Author affiliations

Centre Hospitalier Universitaire Vaudois, 1011 - Lausanne/CH

More

Resources

Reserved to ESMO members

Login Join ESMO

Watch the webcast View the presentation

Resources from the same session

08 Oct 2016

Treatment decisions at ALK TKI resistance

Presenter: Maurice Perol

Session: Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancer

Resources:

Presentation

Webcast

08 Oct 2016

Introduction

Presenter: Yuichiro Ohe

Session: Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancer

Resources:

Presentation

Webcast

08 Oct 2016

Development of a nationwide genomic screening network for lung cancer with rare driver oncogenes and investigation of the mechanism of drug resistance

Presenter: Shingo Matsumoto

Session: Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancer

Resources:

Presentation

Webcast